Inhibition of HPV-16 E7 oncogenic activity by HPV-16 E2

N Gammoh, E Isaacson, V Tomaić, D J Jackson, J Doorbar, L Banks

Research output: Contribution to journalArticlepeer-review

Abstract

Human papillomavirus (HPV) E7 is essential in inducing S-phase progression in differentiating epithelial cells. We have previously shown that HPV-16 E7 activity can be controlled by a direct interaction with the viral transcriptional activator E2, thereby inhibiting transforming potential of E7. We have extended these analyses to show that E2 induces a generalized re-localization of E7 within the cell nucleus, one potential consequence of which is the inhibition of E7-induced degradation of pRb. Most importantly, we show that E2 can also inhibit the ability of E7 to induce centrosome abnormalities, thus preventing aberrant mitoses. Taken together, these studies highlight the central importance of E2 in controlling the functions of E7, independently of the ability of E2 to regulate transcription.
Original languageEnglish
Pages (from-to)2299-304
Number of pages6
JournalOncogene
Volume28
Issue number23
DOIs
Publication statusPublished - 11 Jun 2009

Keywords

  • Blotting, Western
  • Cell Line, Tumor
  • Cell Nucleus
  • Centrosome
  • DNA-Binding Proteins
  • Fluorescent Antibody Technique
  • Gene Expression Regulation, Viral
  • Humans
  • Oncogene Proteins, Viral
  • Papillomavirus E7 Proteins
  • Plasmids
  • Protein Binding
  • Retinoblastoma Protein
  • Reverse Transcriptase Polymerase Chain Reaction
  • Transfection

Fingerprint Dive into the research topics of 'Inhibition of HPV-16 E7 oncogenic activity by HPV-16 E2'. Together they form a unique fingerprint.

Cite this